Profiles of patients with myelomeningocele admitted to the neonatal unit at Universitas Academic Hospital in Bloemfontein, South Africa

Main Article Content

D N Pillay
P Moodley

Abstract





Background. Myelomeningocele (MMC) is a common neural tube defect with significant sequelae. There are limited recent data on the mortality and morbidity of MMC in South Africa (SA).


Objective. To describe the outcomes and characteristics of patients with MMC admitted to the neonatal unit at Universitas Academic Hospital (UAH) in Bloemfontein, SA.


Methods. A retrospective, descriptive study which included 53 patients with MMC admitted to the neonatal unit between 1 January 2017 and 31 December 2019 was conducted. Electronic patient records were reviewed. Data included outcomes, length of stay, complications and maternal and infant characteristics.


Results. The inpatient mortality rate was 11.3% (n=6/53). The median length of stay was 18 days. Notable MMC complications included hydrocephalus (88.7%; n=47/53), Chiari malformation type II (44.7%; n=21/47), lower-limb paralysis (84.9%; n=45/53), lower-limb deformities (60.4%; n=32/53), meningitis (52.8%; n=28/53), neuropathic bladder (37.7%; n=20/53) and loss of anal tone (41.5%; n=22/53). MMC repair was performed in 62.2% (n=33/53) and 27.3% (n=9/33) developed complications. Wound sepsis and breakdown were the most common complications (18.2%, n=6/33), with a median 8 days to complications. Antenatal sonar was not performed in 62% (n=31/50) of cases. MMC was detected antenatally in 20% of cases.


Conclusion. The inpatient mortality rate in thisstudy was lower than the mortality rates reported in other low- and middle-income countries although significant morbidity was identified. A lack of quality antenatal care and access to antenatal sonars were barriers to early detection of MMC. Other healthcare system infrastructural failures may be contributory, which highlights the need for ongoing inter- sectoral collaboration for prevention, early detection and management of MMC to improve patient outcomes.





Article Details

Section

Research

How to Cite

Profiles of patients with myelomeningocele admitted to the neonatal unit at Universitas Academic Hospital in Bloemfontein, South Africa. (2023). South African Journal of Child Health, 17(4), 152-156. https://doi.org/10.7196/SAJCH.2023.v17i3.1997

References

Greene NDE, Copp AJ. Neural tube defects NTDs: Neural tube defects. Ann Rev Neurosci 2014;37:221-242. https://doi: 10.1146/annurev-neuro-062012-170354

Yi Y, Lindemann M, Colligs A, Snowball C. Economic burden of neural tube defects and impact of prevention with folic acid: A literature review. Eur J Pediatr 2011;170(11):1391-1400. https://doi: 10.1007/s00431-011-1492-8

Sayed AR, Bourne D, Pattinson R, Nixon J, Henderson B. Decline in the prevalence of neural tube defects following folic acid fortification and its cost-benefit in South Africa. Birth Defects Res Part A - Clin Mol Teratol 2008;82(4):211-216. https://doi.org/10.1002/bdra.20442

Ntimbani J, Kelly A, Lekgwara P. Myelomeningocele – a literature review. Interdiscip Neurosurg 2020;19:100502. https://doi.org/10.1016/j. inat.2019.100502

Fieggen K, Stewart C. Aetiology and antenatal diagnosis of spina bifida. S Afr Med J 2014;104(3):218. https://doi.org/10.7196/SAMJ.8039

Blom HJ, Shaw GM, Den Heijer M, Finnell RH. Neural tube defects and folate: Case far from closed. Nat Rev Neurosci 2006;7(9):724-731. https://doi. org/10.1038/nrn1986

Fieggen G, Fieggen K, Stewart C, et al. Spina bifida: A multidisciplinary perspective on a many-faceted condition. S Afr Med J 2014;104(3):213-217. https://doi.org/10.7196%2FSAMJ.8079

Zugazaga Cortazar A, Martín Martinez C, Duran Feliubadalo C, Bella Cueto MR, Serra L. Magnetic resonance imaging in the prenatal diagnosis of neural tube defects. Insights Imaging 2013;4(2):225-237. https://doi:10.1007/s13244- 013-0223-2

Kumar R, Singhal N. Outcome of meningomyelocele/lipomeningomyelocele in children of Northern India. Pediatr Neurosurg 2007;43(1):7-14. https://doi. org/10.1159/000097518

Teckie G, Krause A, Kromberg JGR. Neural tube defects in Gauteng, South Africa: Recurrence risks and associated factors. S Afr Med J 2013;103(12 Suppl 1):973-977. https://doi.org/10.7196%2FSAMJ.7119

Mashiloane PC, Masekela R. A review of the epidemiology, post-neurosurgical closure complications and outcomes of neonates with open spina bifida. S Afr J Child Health 2020;14(2):75-81. https://doi.org/10.7196%2FSAJCH.2020. v14i2.1638

Mnguni MN, Enicker BC, Madiba TE. A perspective in the management of myelomeningocoele in the KwaZulu-Natal Province of South Africa. Childs

Nerv Syst 2020;36(7):1521-1527. https://doi:10.1007/s00381-020-04506-9

Kancherla V, Oakley GP. Total prevention of folic acid-preventable spina bifida and anencephaly would reduce child mortality in India: Implications in achieving Target 3.2 of the Sustainable Development Goals. Birth Defects Res

;110(5):421-428. https://doi.org/10.1002/bdr2.1175

Schroeder HK, Nunes JC, Madeira L, Moritz JLW, Walz R, Linhares MN.

Postsurgical infection after myelomeningocele repair: A multivariate analysis of 60 consecutive cases. Clin Neurol Neurosurg 2012;114(7):981-985. https:// doi.org/10.1016/j.clineuro.2012.02.034

ShehuBB,AmehEA,IsmailNJ.Spinabifidacystica:SelectivemanagementofZaria, Nigeria. Ann Trop Paediatr 2000;20(3):239-242. https://doi.org/10.1080/02724936. 2000.11748142

Oncel MY, Ozdemir R, Kahilogullari G, Yurttutan S, Erdeve O, Dilmen U. The effect of surgery time on prognosis in newborns with meningomyelocele. J Korean Neurosurg Soc 2012;51(6):359-362. https://doi:10.3340/jkns.2012.51.6.359

Fumagalli M, Parodi A, Ramenghi L, et al. Ultrasound of acquired posterior fossa abnormalities in the newborn. Pediatr Res 2020;87:25-36. https://doi.org/10.1038/s41390-020-0778-9

World Health Organization. Recommendations on Antenatal Care for a Positive Pregnancy Experience. Geneva: WHO, 2016;58-60.